Ribozyme Pharmaceuticals Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Ribozyme Pharmaceuticals Inc. Ribozyme Pharmaceuticals Inc has 56 trademark applications. The latest application filed is for "SIRNATX"
- Company Aliases
- Ribozyme Pharmaceuticals Incorporated
- RIBOZYME PHARMACEUTICALS INCORPORATED,
- RIBOZYME PHARMACEUTICALS, INC.
- Ribozyme Pharmaceuticals, Inc. -
Trademarks Patents
| Patent Application | Date |
|---|---|
| 2'-deoxy-2'-fluoro modified RNA 20060036087 - 10/656270 Eckstein; Fritz ; et al. | 2006-02-16 |
| Enzymatic nucleic acids containing 5'-and/or 3'-cap structures 20050074760 - 10/430562 Matulic-Adamic, Jasenka ; et al. | 2005-04-07 |
| Conjugates and compositions for cellular delivery 20040110296 - 10/427160 Vargeese, Chandra ; et al. | 2004-06-10 |
| Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) 20040102389 - 10/287949 Pavco, Pamela ; et al. | 2004-05-27 |
| Method and reagent for treatment of diseases caused by expression of the c-myc gene 20040033568 - 10/325403 Thompson, James D. ; et al. | 2004-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 